Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 180

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cause of death in patients with lower‐risk myelodysplastic syndrome

Open access
Dayyani, Farshid, Conley, Anthony P., Strom, Sara S., Stevenson, William, Cortes, Jorge E., Borthakur, Gautam, Faderl, Stefan, O'Brien, Susan, Pierce, Sherry, Kantarjian, Hagop, Garcia‐Manero, Guillermo · 2010 · Cancer

Abstract

BACKGROUND: The authors have recently shown that a majority of patients with myelodysplastic syndrome (MDS) classified by the International Prognostic Scoring System as lower risk die without transformation to acute myelogenous leukemia (AML). The cause of death (COD) of these patients is not well understood. Identifying the COD could help to guide early therapy decisions. METHODS: The authors retrospectively analyzed the COD in a cohort of 273 deceased patients with lower‐risk MDS according to the International Prognostic Scoring System at presentation to The University of Texas M. D. Anderson Cancer Center from 1980 to 2004. MDS‐related death was defined as infection, bleeding, transformation to AML, or disease progression. Remaining CODs were classified as non–MDS‐related. RESULTS: Median age at presentation was 66 years (range, 19‐88 years). Overall median survival was 59 weeks (range, 1‐831 weeks). All French‐American‐British leukemia classification subgroups were represented. The percentage of International Prognostic Scoring System low and intermediate‐1 groups were 21% and 79%, respectively. The most common cytogenetic abnormality (9%) was del(5q). Patients received supportive care only. The COD was identified as MDS‐related in 230 of 273 (84%) patients. The most common disease‐related CODs were infection (38%), transformation to AML (15%), and hemorrhage (13%). The most frequent non–disease‐related COD was cardiovascular events (19 of 43 patients). CONCLUSIONS: The majority of patients with low‐ or intermediate‐1 risk MDS will die because of causes related to their underlying disease. Although these results need to be validated in different populations, early therapeutic intervention could be considered in the management of these patients to improve survival. Cancer 2010. © 2010 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.24984

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 180

Metadata

Authors
Dayyani, F., Conley, A. P., Strom, S. S., Stevenson, W., Cortes, J. E., Borthakur, G., Faderl, S., O'Brien, S., Pierce, S., Kantarjian, H., & Garcia‐Manero, G.
Venue
Cancer
Publisher
Wiley
Published
2010-04-20
Volume
116
Issue
9
Pages
2174-2179
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2129580665
Cited by
180
References
2
FWCI
7.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.